QUOTE
Clinical Data, Inc. (CLDA)
$
30.95
 $0.10 (0.32%) Apr 13
|
One Gateway Center Suite 702,
Newton, MA 02458,
United States
+1-617-5279933
http://www.clda.com/ |
|
|
| PRICES |
| Open |
Volume |
| 31.05 |
1.43M |
| High |
Low |
| 31.14 |
30.70 |
|
| VALUATIONS |
| Mkt Cap |
Avg Volume |
| 821 |
0 |
| 52wk High |
52wk Low |
| 33.90 |
27.36 |
|
| RATIOS |
| P/E |
EPS |
| n/a |
n/a |
| BV |
P/BV |
| 0.72 |
42.99 |
|
| STOCKHOLDERS |
| Dividend |
Yield |
| n/a |
n/a |
| Shares |
Inst Owner |
| 26.52 |
|
|
|
|
|
PERFORMANCE
You need to upgrade your Flash Player
|
|
ANNUAL EARNINGS
You need to upgrade your Flash Player
|
|
QUARTERLY EARNINGS (EPS)
You need to upgrade your Flash Player
|
|
SUMMARIES CALENDARS REPORTS
|
|
| Financial Summary (In millions of USD)
|
| |
2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 |
| Income statement |
| Total Revenue |
$15.87 | $52.52 | $24.22 | $37.76 | $31.56 | $34.03 | $10.44 | $13.09 |
| Operating Income |
$0.39 | $2.62 | $1.94 | $-48.89 | $-31.37 | $-48.20 | $-122.78 | $-86.22 |
| Net Income |
$0.12 | $2.17 | $3.40 | $-50.88 | $-37.52 | $-35.33 | $-132.44 | $-88.51 |
| Balance Sheet |
| Total Assets |
$11.20 | $38.32 | $39.15 | $108.23 | $87.49 | $129.45 | $120.20 | $98.95 |
| Total Equity |
$5.35 | $20.26 | $23.81 | $59.79 | $50.72 | $106.08 | $29.41 | $3.89 |
| Total Liabilities |
$5.85 | $18.05 | $15.34 | $48.44 | $36.77 | $23.37 | $90.78 | $95.06 |
| Cash Flow |
| Operating |
$-0.40 | $6.11 | $4.39 | $-6.18 | $-12.87 | $-24.53 | $-60.25 | $-64.58 |
| Investing |
$-0.94 | $-7.05 | $-0.93 | $-1.44 | $0.75 | $-5.19 | $-7.07 | $18.99 |
| Financing |
- | $1.88 | $-1.39 | $11.60 | $18.45 | $69.98 | $69.89 | $39.66 |
| Net Cash Change |
$-0.98 | $1 | $2.37 | $3.05 | $6.85 | $40.68 | $0.42 | $-5.93 |
|
Earning Call Calender
|
| 2010 | 2009 |
2008 |
2007 |
2006 |
09 February 2010
14 June 2010
09 August 2010
08 November 2010
09 November 2010
|
09 February 2009
15 June 2009
10 August 2009
09 November 2009
|
|
|
| |
|
| Earning Call Summary |
Transcripts |
| |
|
| 10K Reports |
Annual Reports |
| |
| Ticker News
|
|
| |
Management
|
|
Executive |
Title |
|
Randal J. Kirk |
Chairman of the Board | |
|
Andrew J. Fromkin |
President, Chief Executive Officer, Director |
|
Carol Reed, M.D. |
Executive Vice President and Chief Medical Officer |
|
Lynn Ferrucci |
Vice President, Human Resources |
|
C. Evan Ballantyne |
Chief Financial Officer, Senior Vice President |
|
Caesar J. Belbel |
Executive Vice President, Chief Legal Officer and Secretary |
|
John A. Schultz |
Senior Vice President, Licensing and Strategic Development (PGxHealth) |
|
Michael Lutz, Ph.D. |
Global General Manager (Cogenics) & Senior Vice President, Pharmacogenetic Partnerships (PGxHealth) |
|
|
|
Sources: Data collected by 123jump.com and Ticker.com from company press releases, filings and corporate websites. Market data: BATS Exchange. Inc
